• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Stroke associated with increasing disability trajectory as compared to myocardial infarction

byShayna BejaimalandAnees Daud
November 1, 2017
in Cardiology, Chronic Disease, Emergency, Imaging and Intervention, Neurology, Public Health
Reading Time: 3 mins read
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Share on FacebookShare on Twitter

1. In this population-based prospective cohort study, the trajectory of increasing disability was significantly steeper after stroke than after myocardial infarction.

2. Further study to determine if this accelerated disability trajectory state after stroke can be intervened on will be needed.

Evidence Rating Level: 2 (Good)

Study Rundown: It is thought that stroke causes disability acutely, and after the recovery period, the slope of ones disability trajectory is the same as those without strokes. However, this paradigm may not be accurate. It is now proposed that vascular brain injury may accelerate the disability and deterioration of functional status over time, even without recurrent events. This population-based prospective cohort study aimed to test whether the increase in long-term disability is steeper after than before the event for ischemic stroke but not myocardial infarction (MI).

The trajectory of increasing disability became significantly steeper after stroke but not after MI. The annual increase in disability after stroke more than tripled after stroke where the increase in disability before and MI did not differ significantly. Strengths of this study included its use of a large nationally-based representative cohort of elderly community-dwelling participants, however the sample size was small due to the need for before and after disability measurements to determine the trajectory. Also, details regarding the location, size and severity of stroke were not available and thus not accounted for in trajectory calculations.

Click to read the study, published in JAMA Neurology

RELATED REPORTS

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

Thrombectomy may improve functional independence in acute ischemic stroke with medium vessel occlusion

2 Minute Medicine Rewind April 20, 2026

Relevant Reading: Long-Term Functional Recovery After First Ischemic Stroke: The Northern Manhattan Study

In-Depth [prospective cohort]: This large-scale prospective cohort study was conducted using patient data from the Cardiovascular Health Study (1989-2013) and included community dwelling adults aged 65 and older from a sex- and age-stratified random sample of Medicare-eligible individuals in 4 states. Individuals needing a wheelchair, receiving hospice care or undergoing radiotherapy were also excluded. Baseline sociodemographic, functional and health data were gathered. Participants were followed for a mean (SD) of 13 (6.2) years. Exposure of interest was stroke (classified into ischemic, hemorrhagic or unknown) and MI (based on clinical history, elevated cardiac enzymes and ECG changes). The outcomes of interest were disability as assessed annually by activities of daily living (ADL) and instrumental ADL (IADL) scales and determined before and after the exposure of interest.

The mean age of the cohort (n = 5888) was 72.8 years old. There were similar incidences of stroke (n = 382) and MI (n = 395) during follow up. There were a similar mean (SD) number of visits for assessment before stroke (3.7 [2.4]) and MI (3.8 [2.5]) and after stroke (3.7 [2.3]) and MI (3.8 [2.4]). As expected there was a greater increase in disability around the time of the event for stroke as compared to MI (stroke: 0.88 points on disability scale; 95% CI 0.57-1.20, p < 0.001, MI: 0.20 points on disability scale, 95% CI 0.06-0.35, p = 0.006). The annual increase in disability after stroke more than tripled after stroke (before stroke: 0.06 points on disability scale per year; 95% CI 0.002-0.12, p = 0.04, after stroke: 0.15 additional points per year; 95% CI 0.004-0.30, p = 0.04). There was no significant difference in the annual increase in disability before or after MI (before MI: 0.04 points per year; 95% CI 0.004-0.08, p = 0.03; after MI: 0.02 additional points per year; 95% CI -0.07-0.11, p = 0.69).

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ischemic strokemyocardial infarction
Previous Post

2 Minute Medicine Rewind October 30, 2017

Next Post

High nicotine concentration in e-cigarettes linked to increased smoking and vaping in teenagers

RelatedReports

Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
No obesity paradox found between BMI, stroke, and death
Neurology

Thrombectomy may improve functional independence in acute ischemic stroke with medium vessel occlusion

May 26, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Weekly Rewinds

2 Minute Medicine Rewind April 20, 2026

April 20, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Chronic Disease

Virtual reality rehabilitation is safe and feasible for upper extremity recovery after subacute ischemic stroke

February 25, 2026
Next Post
Smoking during pregnancy associated with aerobic fitness of children

High nicotine concentration in e-cigarettes linked to increased smoking and vaping in teenagers

Higher parental monitoring linked to safer sex in teens

Despite improving trends in lupus-related mortality, rates appear to remain high relative to non-lupus causes

Normal renal ultrasound only rules out high grade vesicoureteral reflux in infants

More physicians are choosing shorter intravenous antibiotic courses for infantile urinary tract infections

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.